Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Tengion Announces Significant Advances in Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM) Programs 


MarketWatch (press release)
WINSTON-SALEM, NC, March 26, 2012 /PRNewswire via COMTEX/ -- Tengion, Inc. (NASDAQ:TNGN) , a leader in regenerative medicine, today announced that it has made significant advances in its two lead programs. A fourth patient was implanted in the last ...
Read more:


Posted on 27-Mar-12 by Geier, Eric
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: